New injectables aim to restore youthful skin after menopause
NCT ID NCT07205744
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study tests two injectable treatments—Sculptra and Restylane Skinboosters—to improve skin hydration and firmness in 50 post-menopausal women aged 40-65. The goal is to reduce common skin issues like dryness, thinning, and loss of elasticity. Participants receive injections and are monitored for several months to see if their skin looks and feels better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AESTHETIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Erevna Innovations Inc.
Montreal, Quebec, H3Z 1C3, Canada
Conditions
Explore the condition pages connected to this study.